Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (DFPH) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for Oncology Institute (DFPH) over the last 6 years, with Q3 2025 value amounting to -$0.14.

  • Oncology Institute's EPS (Basic) rose 2222.22% to -$0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.65, marking a year-over-year increase of 1666.67%. This contributed to the annual value of -$0.71 for FY2024, which is 2325.78% up from last year.
  • Per Oncology Institute's latest filing, its EPS (Basic) stood at -$0.14 for Q3 2025, which was up 2222.22% from -$0.15 recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's EPS (Basic) ranged from a high of $0.22 in Q1 2022 and a low of -$0.33 during Q1 2023
  • In the last 5 years, Oncology Institute's EPS (Basic) had a median value of -$0.15 in 2025 and averaged -$0.12.
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 22167862155.53% in 2021, then surged by 120000.0% in 2022.
  • Quarter analysis of 5 years shows Oncology Institute's EPS (Basic) stood at -$0.15 in 2021, then decreased by 0.81% to -$0.15 in 2022, then crashed by 68.18% to -$0.25 in 2023, then soared by 43.27% to -$0.14 in 2024, then rose by 2.95% to -$0.14 in 2025.
  • Its last three reported values are -$0.14 in Q3 2025, -$0.15 for Q2 2025, and -$0.21 during Q1 2025.